ProciseDx Earns CE Mark for C-Reactive Protein Assay

ProciseDx has earned the CE Mark for its Procise C reactive protein (CRP) assay, a point-of-care diagnostic used with its ProciseDx rapid diagnostic testing platform.

CRP is often used as a biomarker to evaluate patients for infection or inflammation caused by autoimmune diseases. It can also be used to predict a patient’s future risk of cardiovascular disease.

The diagnostic system, which is about the size of a shoebox, uses a finger prick of blood or stool sample to deliver test results in two to five minutes.